• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建立并验证一个列线图模型预测原发性腹膜后肉瘤手术切除后发病率。

Development and validation of a nomogram for predicting morbidity in surgically resected primary retroperitoneal sarcoma.

机构信息

Department of Neurology, Department of Medical Oncology, Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China.

Xiamen University Research Center of Retroperitoneal Tumor Committee of Oncology Society of Chinese Medical Association, Xiamen University, Xiamen, Fujian, China.

出版信息

BMC Surg. 2023 Feb 23;23(1):42. doi: 10.1186/s12893-023-01941-8.

DOI:10.1186/s12893-023-01941-8
PMID:36814201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9948406/
Abstract

BACKGROUND

Surgery is the cornerstone of the treatment for primary retroperitoneal sarcoma (RPS). The purpose of this study was to establish a nomogram predictive model for predicting postoperative morbidity in primary RPS.

METHODS

Clinicopathological data of patients who underwent radical resection from 2009 to 2021 were retrospectively analyzed. Risk factor analysis was performed using a logistic regression model, and modeling variables were selected based on Akaike Information Criterion. The nomogram prediction model was built on the basis of a binary logistic regression model and internally validated by calibration curves and concordance index.

RESULTS

A total of 319 patients were enrolled, including 162 males (50.8%). 22.9% (n = 73) were over 65 years of age, and 70.2% (n = 224) had tumors larger than 10 cm. The most common histologic subtypes were well-differentiated liposarcoma (38.2%), dedifferentiated liposarcoma (25.1%) and leiomyosarcoma (7.8%). According to the Clavien-Dindo Classification, 96 (31.1%) and 31 (11.6%) patients had grade I-II complications and grade III-V complications, respectively. Age, tumor burden, location, operative time, number of combined organ resections, weighted resected organ score, estimated blood loss and packed RBC transfusion was used to construct the nomogram, and the concordance index of which was 0.795 (95% CI 0.746-0.844). and the calibration curve indicated a high agreement between predicted and actual rates.

CONCLUSIONS

Nomogram, a visual predictive tool that integrates multiple clinicopathological factors, can help physicians screen RPS patients at high risk for postoperative complications and provide a basis for early intervention.

摘要

背景

手术是原发性腹膜后肉瘤(RPS)治疗的基石。本研究旨在建立预测原发性 RPS 术后发病率的列线图预测模型。

方法

回顾性分析 2009 年至 2021 年接受根治性切除术的患者的临床病理数据。使用逻辑回归模型进行风险因素分析,并根据赤池信息量准则选择建模变量。基于二项逻辑回归模型构建列线图预测模型,并通过校准曲线和一致性指数进行内部验证。

结果

共纳入 319 例患者,其中男性 162 例(50.8%)。22.9%(n=73)患者年龄超过 65 岁,70.2%(n=224)肿瘤大于 10cm。最常见的组织学亚型是高分化脂肪肉瘤(38.2%)、去分化脂肪肉瘤(25.1%)和平滑肌肉瘤(7.8%)。根据 Clavien-Dindo 分类,96(31.1%)和 31(11.6%)例患者分别发生 I-II 级和 III-V 级并发症。年龄、肿瘤负担、位置、手术时间、联合器官切除数量、加权切除器官评分、估计失血量和红细胞悬液输注用于构建列线图,其一致性指数为 0.795(95%CI 0.746-0.844)。校准曲线表明预测率与实际率之间具有高度一致性。

结论

列线图是一种整合多个临床病理因素的可视化预测工具,可以帮助医生筛选术后并发症风险较高的 RPS 患者,并为早期干预提供依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb3e/9948406/638fc9e88974/12893_2023_1941_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb3e/9948406/6acab267d001/12893_2023_1941_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb3e/9948406/704caa777862/12893_2023_1941_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb3e/9948406/4c7d2fc8ce7e/12893_2023_1941_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb3e/9948406/638fc9e88974/12893_2023_1941_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb3e/9948406/6acab267d001/12893_2023_1941_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb3e/9948406/704caa777862/12893_2023_1941_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb3e/9948406/4c7d2fc8ce7e/12893_2023_1941_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb3e/9948406/638fc9e88974/12893_2023_1941_Fig4_HTML.jpg

相似文献

1
Development and validation of a nomogram for predicting morbidity in surgically resected primary retroperitoneal sarcoma.建立并验证一个列线图模型预测原发性腹膜后肉瘤手术切除后发病率。
BMC Surg. 2023 Feb 23;23(1):42. doi: 10.1186/s12893-023-01941-8.
2
A multi-institutional validation study of prognostic nomograms for retroperitoneal sarcoma.多机构验证研究:腹膜后肉瘤预后列线图。
J Surg Oncol. 2021 Oct;124(5):829-837. doi: 10.1002/jso.26586. Epub 2021 Jul 13.
3
External validation of a multi-institutional retroperitoneal sarcoma nomogram.多机构腹膜后肉瘤列线图的外部验证。
Cancer. 2016 May 1;122(9):1417-24. doi: 10.1002/cncr.29931. Epub 2016 Feb 24.
4
Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk.针对腹膜后、四肢或躯干原发性脂肪肉瘤患者的亚型特异性预后列线图。
Ann Surg. 2006 Sep;244(3):381-91. doi: 10.1097/01.sla.0000234795.98607.00.
5
Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG.预测接受局部复发性腹膜后肉瘤切除术患者的生存:TARPSWG 的研究和新的列线图。
Clin Cancer Res. 2019 Apr 15;25(8):2664-2671. doi: 10.1158/1078-0432.CCR-18-2700. Epub 2019 Feb 5.
6
Postoperative Morbidity After Radical Resection of Primary Retroperitoneal Sarcoma: A Report From the Transatlantic RPS Working Group.原发性腹膜后肉瘤根治性切除术后的术后发病率:来自跨大西洋 RPS 工作组的报告。
Ann Surg. 2018 May;267(5):959-964. doi: 10.1097/SLA.0000000000002250.
7
Postoperative Morbidity After Resection of Recurrent Retroperitoneal Sarcoma: A Report from the Transatlantic Australasian RPS Working Group (TARPSWG).复发性腹膜后肉瘤切除术后的并发症:跨大西洋澳大利亚腹膜后肉瘤工作组(TARPSWG)的报告
Ann Surg Oncol. 2021 May;28(5):2705-2714. doi: 10.1245/s10434-020-09445-y. Epub 2021 Jan 2.
8
Longitudinal prognostication in retroperitoneal sarcoma survivors: Development and external validation of two dynamic nomograms.腹膜后肉瘤幸存者的纵向预后:两个动态列线图的建立和外部验证。
Eur J Cancer. 2021 Nov;157:291-300. doi: 10.1016/j.ejca.2021.08.008. Epub 2021 Sep 20.
9
Surgically Treated Retroperitoneal Sarcoma: A Population-based Competing Risks Analysis.手术治疗腹膜后肉瘤:基于人群的竞争风险分析。
Eur Urol Oncol. 2018 Sep;1(4):346-351. doi: 10.1016/j.euo.2018.05.008. Epub 2018 May 31.
10
Postoperative nomogram for survival of patients with retroperitoneal sarcoma treated with curative intent.根治性治疗后腹膜肉瘤患者生存的术后列线图。
Ann Oncol. 2010 Feb;21(2):397-402. doi: 10.1093/annonc/mdp298. Epub 2009 Jul 21.

引用本文的文献

1
Surgical Outcome in Retroperitoneal Sarcoma Surgery: Accuracy of P-POSSUM, ACS-NSQIP, and Inflammatory Biomarkers Prognostic Index (IBPI) Risk-Calculators for Prediction of Severe and Overall Morbidity.腹膜后肉瘤手术的外科治疗结果:P-POSSUM、ACS-NSQIP 和炎症生物标志物预后指数 (IBPI) 风险计算器预测严重和总体发病率的准确性。
Ann Surg Oncol. 2024 Nov;31(12):7957-7966. doi: 10.1245/s10434-024-15861-1. Epub 2024 Jul 26.

本文引用的文献

1
Postoperative Morbidity After Radical Resection of Retroperitoneal Solitary Fibrous Tumor.腹膜后孤立性纤维瘤根治性切除术后的并发症
Front Surg. 2022 Mar 28;9:833296. doi: 10.3389/fsurg.2022.833296. eCollection 2022.
2
The Evolution, Current Value, and Future of the American Society of Anesthesiologists Physical Status Classification System.美国麻醉医师协会体格状况分类系统的演变、现状和未来。
Anesthesiology. 2021 Nov 1;135(5):904-919. doi: 10.1097/ALN.0000000000003947.
3
Cumulative Burden of Postoperative Complications in Patients Undergoing Surgery for Primary Retroperitoneal Sarcoma.
原发性腹膜后肉瘤患者术后并发症的累积负担。
Ann Surg Oncol. 2021 Nov;28(12):7939-7949. doi: 10.1245/s10434-021-10059-1. Epub 2021 May 12.
4
Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group.成人原发性腹膜后肉瘤(RPS)的治疗:来自跨大西洋澳大拉西亚 RPS 工作组的最新共识方法。
Ann Surg Oncol. 2021 Nov;28(12):7873-7888. doi: 10.1245/s10434-021-09654-z. Epub 2021 Apr 14.
5
The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives.2020 年世界卫生组织软组织肿瘤分类:新闻与展望。
Pathologica. 2021 Apr;113(2):70-84. doi: 10.32074/1591-951X-213. Epub 2020 Nov 3.
6
Morbidity, mortality and temporal trends in the surgical management of retroperitoneal sarcoma: An ACS-NSQIP follow up analysis.腹膜后肉瘤外科治疗的发病率、死亡率及时间趋势:一项美国外科医师学会国家外科质量改进计划的随访分析
J Surg Oncol. 2019 Sep;120(4):753-760. doi: 10.1002/jso.25649. Epub 2019 Jul 29.
7
Long-Term Outcome After Surgery for a Localized Retroperitoneal Soft Tissue Sarcoma in Elderly Patients: Results from a Retrospective, Single-Center Study.老年局限性腹膜后软组织肉瘤患者的手术治疗长期预后:一项回顾性单中心研究的结果。
Ann Surg Oncol. 2018 Aug;25(8):2201-2208. doi: 10.1245/s10434-018-6529-z. Epub 2018 May 24.
8
Postoperative Morbidity After Radical Resection of Primary Retroperitoneal Sarcoma: A Report From the Transatlantic RPS Working Group.原发性腹膜后肉瘤根治性切除术后的术后发病率:来自跨大西洋 RPS 工作组的报告。
Ann Surg. 2018 May;267(5):959-964. doi: 10.1097/SLA.0000000000002250.
9
Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS): A Report on 1007 Patients From the Multi-institutional Collaborative RPS Working Group.原发性腹膜后肉瘤(RPS)切除术后复发模式的变异性:来自多机构协作RPS工作组的1007例患者报告。
Ann Surg. 2016 May;263(5):1002-9. doi: 10.1097/SLA.0000000000001447.
10
Quality of life in patients with peritoneal surface malignancies after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.减瘤手术及腹腔内热灌注化疗后腹膜表面恶性肿瘤患者的生活质量
Eur J Surg Oncol. 2014 Aug;40(8):909-16. doi: 10.1016/j.ejso.2013.12.028. Epub 2014 Apr 13.